Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: A multi-centre, placebo-controlled study

European Journal of Pain

Volumn 5, Issue 2, 2001, Pages 199-207

  Sjölund, Karl Fredrik ^a   Belfrage, Måns ^b   Karlsten, Rolf ^c   Segerdahl, Märta ^a   Arnér, Staffan ^a   Gordh, Torsten ^c   Sollevi, Alf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b St Görans Hospital   (United Kingdom)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allodynia; Hyperalgesia; Neuropathy; Pain; Placebo response; Sensory tests

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; PLACEBO;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERALGESIA; MALE; MULTICENTER STUDY; NEUROMODULATION; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PSYCHOPHYSICS; RANDOMIZED CONTROLLED TRIAL; TACTILE STIMULATION;

EID: 0034905273     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2001.0237     Document Type: Article

References (37)

1. Prolonged relief of neuralgia after local anaesthetic blocks. A call for further experimental and systematic clinical studies
2. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain
3. Safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain
4. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
5. Intravenous regional sympatholysis: A double-blind comparison of guanethidine, reserpine, and normal saline
6. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats
7. Spinal cord pharmacology of pain
8. The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury
9. Adenosine and neuropathic pain
10. Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain
11. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-etylcarboxamide-adenosine on nociception and motor function in the rat
12. An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection
13. How do drugs relieve neurogenic pain?
14. Dynamic and static components of mechanical hyperalgesia in human hairy skin
15. Nociceptor modulated central sensitisation causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain
16. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
17. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
18. Adenosine inhibition of synaptic transmission in the substantia gelatinosa
19. Adenosine for pain relief in a patient with intractable secondary erythromelalgia
20. Pain mechanisms in neuropathy
21. Examiner expectancy effects in the measurement of pressure pain thresholds
22. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
23. A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy. A controlled, randomised, double-blind crossover study
24. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn
25. The role of purines in nociception
26. Adenosine receptor activation and nociception
27. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans
28. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics
29. 1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain
30. Intrathecal and systemic R-phenylisopropyl adenosine reduces scratching behaviour in a rat mononeuropathy model
31. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain
32. Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain
33. Spinal R-phenyl-isopropyl adenosine inhibits spinal dorsal horn neurones responding to noxious heat stimulation in the absence and presence of sensitisation
34. High incidence of placebo responders among chronic neuropathic pain patients
35. Excitability changes in central neurones following peripheral damage, role of central sensitisation in the pathogenesis of pain
36. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve